Aadi Bioscience Inc. (AADI)
2.31
-0.25 (-9.77%)
At close: Mar 03, 2025, 3:59 PM
2.41
4.56%
After-hours: Mar 03, 2025, 07:17 PM EST
Aadi Bioscience Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 24.35M | 15.22M | 1M | 14M | 749K | 20.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 2.81M | 1.33M | 276K | 176K | 76.5K | n/a | 51.27K | 69.67K | 57.98K | 23.97K | 22.82K | 22.39K | 23.59K | 20.51K | n/a | n/a |
| Gross Profit | 21.55M | 13.88M | 724K | 13.82M | 672.5K | 20.16M | -51.27K | -69.67K | -57.98K | -23.97K | -22.82K | -22.39K | -23.59K | -20.51K | n/a | n/a |
| Operating Income | -71.93M | -58.96M | -111.22M | -2.55M | -22.58M | -11.18M | -21.39M | -16.63M | -17.49M | -22.82K | -22.39K | -23.59K | -20.51K | -41.02K | n/a | -33.62K |
| Interest Income | 6.4M | 2.4M | 13K | 41K | 1.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -65.77M | -60.51M | -110.09M | -3.48M | -23.27M | -10.4M | -21.4M | -16.98M | -17.07M | -28.7K | -27.36K | -27.18K | -22.39K | -22.39K | n/a | -33.62K |
| Net Income | -65.77M | -57.01M | -110.09M | -3.48M | -23.27M | -10.4M | -21.4M | -16.98M | -17.07M | -28.7K | -27.36K | -27.18K | -22.39K | -22.39K | n/a | -33.62K |
| Selling & General & Admin | 44.55M | 40.18M | 18.51M | 2.12M | 9.68M | 13.44M | 9.19M | 5.2M | 5.8M | 22.82K | 22.39K | 23.59K | 20.51K | 20.51K | n/a | n/a |
| Research & Development | 48.93M | 32.66M | 19.67M | 15.01M | 12.82M | 17.85M | 12.15M | 11.37M | 11.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | 5.06M | -120K | -580K | -142.73K | -6.39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -33.62K |
| Operating Expenses | 93.48M | 72.84M | 38.06M | 16.55M | 22.5M | 31.29M | 21.34M | 16.56M | 17.43M | 22.82K | 22.39K | 23.59K | 20.51K | 20.51K | n/a | -33.62K |
| Interest Expense | 231K | 230K | 665K | 815K | n/a | 778.22K | -105.78K | 9.94K | 8.43K | 5.88K | 4.97K | 3.6K | 1.89K | 1.89K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 7.83M | -46.69K | -51.27K | 5.17M | 5.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 96.29M | 74.17M | 38.06M | 16.55M | 22.58M | 31.34M | 21.39M | 16.63M | 17.49M | 22.82K | 22.39K | 23.59K | 20.51K | 41.02K | n/a | -33.62K |
| Income Tax | n/a | -3.5M | 2K | 2K | 1.3K | 778.22K | -12.06K | -3 | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 26.92M | 22.51M | 8.92M | 169.49K | 2.71M | 2.26M | 1.44M | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 5M | n/a | n/a |
| Shares Outstanding (Diluted) | 26.92M | 22.51M | 8.92M | 169.49K | 2.71M | 2.26M | 1.44M | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 5M | n/a | n/a |
| EPS (Basic) | -2.44 | -2.53 | -12.34 | -20.52 | -8.6 | -4.6 | -14.81 | -9.42 | -9.47 | -0.02 | -0.02 | -0.02 | -0.01 | -0.00 | n/a | n/a |
| EPS (Diluted) | -2.44 | -2.53 | -12.34 | -20.52 | -8.6 | -4.6 | -14.81 | -9.42 | -9.47 | -0.02 | -0.02 | -0.02 | -0.01 | -0.00 | n/a | n/a |
| EBITDA | -65.36M | -60.12M | -109.15M | -2.48M | -24.44M | -10.35M | -21.24M | -16.43M | -17.01M | -22.82K | -22.39K | -23.59K | -20.51K | -41.02K | n/a | -33.62K |
| Depreciation & Amortization | 169K | 159K | 276K | 176K | 76.5K | 46.69K | 51.27K | 69.67K | 57.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |